15 Stocks Moving in Monday's Pre-Market Session



  • Trevi Therapeutics, Inc. TRVI rose 32.5% to $1.59 in pre-market trading after the company filed Friday to withdraw its offering of shares.
  • Nutriband Inc. NTRB shares rose 12.1% to $7.51 in pre-market trading after dropping over 14% on Friday.
  • Avadel Pharmaceuticals plc AVDL rose 10% to $11.00 in pre-market trading.
  • Liquidia Corporation LQDA rose 9.9% to $3.00 in pre-market trading after the company received favorable ruling in Inter Partes Review against United Therapeutics patent.
  • Borr Drilling Limited BORR shares rose 7.7% to $1.11 in pre-market trading.
  • Camber Energy, Inc. CEI rose 7.6% to $1.84 in pre-market trading after declining 4% on Friday.
  • Yumanity Therapeutics, Inc. YMTX rose 6.9% to $9.80 in pre-market trading.
  • U.S. Well Services, Inc. USWS rose 6.7% to $2.56 in pre-market trading.
  • Luokung Technology Corp. LKCO rose 6.3% to $1.18 in pre-market trading after declining over 3% on Friday.
  • AIkido Pharma Inc. AIKI shares rose 5.6% to $0.9185 in pre-market trading. HC Wainwright & Co. initiated coverage on AIkido Pharma with a Buy rating and announced a price target of $2.
  • Matinas BioPharma Holdings, Inc. MTNB rose 4.7% to $1.11 in pre-market trading.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers


  • Cellectis S.A. CLLS fell 6% to $8.57 in pre-market trading after tumbling 24% on Friday. Baird downgraded Cellectis from Outperform to Neutral and lowered the price target from $39 to $10.
  • Valneva SE VALN fell 5.2% to $27.89 in pre-market trading after gaining around 3% on Friday.
  • Romeo Power, Inc. RMO fell 4.5% to $4.43 in pre-market trading. Romeo Power recentlu leased a new Class A, state-of-the-art headquarters and manufacturing facility in Cypress, California.
  • Aditxt, Inc. ADTX shares fell 4% to $1.70 in pre-market trading. Aditxt recently agreed to acquire AiPharma Global Holdings LLC, focused on discovering, developing, and commercializing antiviral therapies.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!